By Helgi Analytics - August 3, 2020
Zur Rose made a net profit of CHF -17.6 mil with revenues of CHF 344 mil in 4Q2019, down by 64.3% and up by 13.7%, re...
By Helgi Analytics - August 3, 2020
Zur Rose's operating cash flow stood at CHF -33.6 mil in 4Q2019, down 239% when compared to the previous year. Historica...
By Helgi Analytics - October 12, 2020
Zur Rose's total assets reached CHF 992 mil at the end of 4Q2019, up 36.5% compared to the previous year. Current ...
| Profit Statement | 2017 | 2018 | 2019 | |
| Sales | CHF mil | 983 | 1,207 | 1,356 |
| EBITDA | CHF mil | -21.2 | -14.0 | -13.8 |
| EBIT | CHF mil | -38.3 | -32.9 | -45.7 |
| Financing Cost | CHF mil | 2.30 | 1.70 | 4.40 |
| Pre-Tax Profit | CHF mil | -36.5 | -38.5 | -50.1 |
| Net Profit | CHF mil | -36.2 | -39.0 | -52.4 |
| Dividends | CHF mil | 0 | 0 | 0 |
| Balance Sheet | 2017 | 2018 | 2019 | |
| Total Assets | CHF mil | 462 | 727 | 992 |
| Non-Current Assets | CHF mil | 188 | 310 | 564 |
| Current Assets | CHF mil | 273 | 417 | 428 |
| Working Capital | CHF mil | 68.0 | 78.6 | 105 |
| Shareholders' Equity | CHF mil | 294 | 444 | 406 |
| Liabilities | CHF mil | 168 | 283 | 586 |
| Total Debt | CHF mil | 13.2 | 148 | 438 |
| Net Debt | CHF mil | -94.7 | -82.6 | 233 |
| Ratios | 2017 | 2018 | 2019 | |
| ROE | % | -18.2 | -10.6 | -12.3 |
| ROCE | % | -17.8 | -12.1 | -9.90 |
| EBITDA Margin | % | -2.16 | -1.16 | -1.02 |
| EBIT Margin | % | -3.90 | -2.72 | -3.37 |
| Net Margin | % | -3.69 | -3.23 | -3.86 |
| Net Debt/EBITDA | 4.47 | 5.90 | -16.8 | |
| Net Debt/Equity | % | -32.2 | -18.6 | 57.4 |
| Cost of Financing | % | 6.73 | 2.10 | 1.50 |
| Valuation | 2017 | 2018 | 2019 | |
| Market Capitalisation | USD mil | 832 | 758 | 961 |
| Enterprise Value (EV) | USD mil | 735 | 674 | 1,202 |
| Number Of Shares | mil | 5.22 | 6.35 | 8.66 |
| Share Price | CHF | 131 | 89.7 | 107 |
| EV/EBITDA | -34.6 | -47.2 | -84.8 | |
| EV/Sales | 0.745 | 0.547 | 0.866 | |
| Price/Earnings (P/E) | -18.9 | -14.6 | -17.7 | |
| Price/Book Value (P/BV) | 2.32 | 1.28 | 2.29 | |
| Dividend Yield | % | 0 | 0 | 0 |
Get all company financials in excel:
| overview | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | ||||||||||||
| Sales | CHF mil | 911 | 916 | 834 | 880 | 983 | ||||||
| EBIT | CHF mil | -11.3 | 8.21 | 8.44 | -7.09 | -38.3 | ||||||
| Net Profit | CHF mil | -15.5 | 7.15 | 3.45 | -12.8 | -36.2 | ||||||
| ROE | % | ... | -19.4 | 9.49 | 4.59 | -14.5 | -18.2 | |||||
| EBIT Margin | % | -1.24 | 0.897 | 1.01 | -0.806 | -3.90 | ||||||
| Net Margin | % | -1.70 | 0.781 | 0.413 | -1.45 | -3.69 | ||||||
| Employees | 736 | 702 | 716 | 752 | 1,106 | |||||||
| balance sheet | ||||||||||||
| Total Assets | CHF mil | 225 | 228 | 233 | 262 | 462 | ||||||
| Non-Current Assets | CHF mil | 75.5 | 83.0 | 91.1 | 102 | 188 | ||||||
| Current Assets | CHF mil | 150 | 145 | 142 | 160 | 273 | ||||||
| Shareholders' Equity | CHF mil | 73.4 | 77.4 | 72.8 | 104 | 294 | ||||||
| Liabilities | CHF mil | 152 | 151 | 161 | 158 | 168 | ||||||
| Non-Current Liabilities | CHF mil | 64.9 | 66.7 | 72.0 | 19.5 | 48.5 | ||||||
| Current Liabilities | CHF mil | 86.8 | 84.1 | 88.7 | 138 | 119 | ||||||
| Net Debt/EBITDA | 5.80 | 2.12 | 2.05 | 13.9 | 4.47 | |||||||
| Net Debt/Equity | % | 36.9 | 47.5 | 44.5 | 28.5 | -32.2 | ||||||
| Cost of Financing | % | ... | 3.61 | 4.05 | 4.25 | 4.40 | 6.73 | |||||
| cash flow | ||||||||||||
| Total Cash From Operations | CHF mil | 2.00 | 7.20 | 18.9 | -13.8 | -22.2 | ||||||
| Total Cash From Investing | CHF mil | -11.1 | -16.0 | -16.4 | -23.1 | -62.2 | ||||||
| Total Cash From Financing | CHF mil | -14.9 | -1.06 | 2.50 | 37.0 | 166 | ||||||
| Net Change In Cash | CHF mil | -23.7 | -10.1 | 3.97 | 0.136 | 82.5 | ||||||
| valuation | ||||||||||||
| Market Capitalisation | USD mil | 90.2 | 77.1 | 72.3 | 320 | 832 | ||||||
| Enterprise Value (EV) | USD mil | 116 | 113 | 104 | 349 | 735 | ||||||
| Number Of Shares | mil | 3.07 | 3.21 | 3.21 | 3.55 | 5.22 | ||||||
| Share Price | CHF | 25.0 | 23.9 | 22.5 | 75.7 | 131 | ||||||
| Price/Earnings (P/E) | -4.96 | 10.7 | 21.0 | -21.0 | -18.9 | |||||||
| Price/Cash Earnings (P/CE) | -6.09 | 8.17 | 12.5 | -28.2 | -21.1 | |||||||
| EV/EBITDA | 23.2 | 6.12 | 6.54 | 165 | -34.6 | |||||||
| Price/Book Value (P/BV) | 1.05 | 0.993 | 0.992 | 2.59 | 2.32 | |||||||
| Dividend Yield | % | 0 | 0 | 0 | 0 | 0 |
| income statement | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | ||||||||||||
| Sales | CHF mil | 911 | 916 | 834 | 880 | 983 | ||||||
| Selling, General & Admin | CHF mil | 49.7 | 40.7 | 34.1 | 43.7 | 61.1 | ||||||
| Research & Development | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Operating Expense | CHF mil | 871 | 863 | 791 | 839 | 958 | ||||||
| Staff Cost | CHF mil | 60.5 | 57.8 | 53.7 | 60.2 | 78.3 | ||||||
| Other Operating Cost (Income) | CHF mil | 6.94 | 5.30 | 6.33 | 5.40 | 9.74 | ||||||
| EBITDA | CHF mil | 4.66 | 17.3 | 15.8 | 2.12 | -21.2 | ||||||
| Depreciation | CHF mil | 2.86 | 2.25 | 2.33 | 3.25 | 3.85 | ||||||
| EBIT | CHF mil | -11.3 | 8.21 | 8.44 | -7.09 | -38.3 | ||||||
| Net Financing Cost | CHF mil | 2.35 | 2.36 | 2.30 | 2.47 | 2.30 | ||||||
| Financing Cost | CHF mil | 2.47 | 2.37 | 2.47 | 2.48 | 2.30 | ||||||
| Financing Income | CHF mil | 0.122 | 0.008 | 0.165 | 0.013 | 0 | ||||||
| FX (Gain) Loss | CHF mil | -0.429 | 0.265 | 1.47 | 0.404 | -4.28 | ||||||
| (Income) / Loss from Affiliates | CHF mil | 0.200 | -0.044 | 0.716 | 0.630 | -0.134 | ||||||
| Extraordinary Cost | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||
| Pre-Tax Profit | CHF mil | -14.3 | 4.52 | 4.04 | -12.7 | -36.5 | ||||||
| Tax | CHF mil | 1.19 | -2.64 | 0.598 | 0.053 | -0.241 | ||||||
| Minorities | CHF mil | 0 | 0 | 0 | 0 | -0.027 | ||||||
| Net Profit | CHF mil | -15.5 | 7.15 | 3.45 | -12.8 | -36.2 | ||||||
| Net Profit Avail. to Common | CHF mil | -15.5 | 7.15 | 3.45 | -12.8 | -36.2 | ||||||
| Dividends | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||
| growth rates | ||||||||||||
| Total Revenue Growth | % | ... | 74.0 | 0.543 | -8.86 | 5.41 | 11.8 | |||||
| Operating Cost Growth | % | ... | 73.3 | -1.74 | -8.80 | 7.17 | 15.6 | |||||
| Staff Cost Growth | % | ... | 106 | -4.38 | -7.08 | 12.0 | 30.2 | |||||
| EBITDA Growth | % | ... | -80.6 | 272 | -8.88 | -86.6 | -1,098 | |||||
| EBIT Growth | % | ... | -250 | -173 | 2.81 | -184 | 440 | |||||
| Pre-Tax Profit Growth | % | ... | -318 | -132 | -10.5 | -415 | 187 | |||||
| Net Profit Growth | % | ... | -352 | -146 | -51.8 | -471 | 184 | |||||
| ratios | ||||||||||||
| ROE | % | ... | -19.4 | 9.49 | 4.59 | -14.5 | -18.2 | |||||
| ROA | % | ... | -6.30 | 3.16 | 1.49 | -5.16 | -10.0 | |||||
| ROCE | % | ... | -12.3 | 5.56 | 2.63 | -9.22 | -17.8 | |||||
| EBITDA Margin | % | 0.512 | 1.89 | 1.89 | 0.241 | -2.16 | ||||||
| EBIT Margin | % | -1.24 | 0.897 | 1.01 | -0.806 | -3.90 | ||||||
| Net Margin | % | -1.70 | 0.781 | 0.413 | -1.45 | -3.69 | ||||||
| Payout Ratio | % | 0 | 0 | 0 | 0 | 0 | ||||||
| Cost of Financing | % | ... | 3.61 | 4.05 | 4.25 | 4.40 | 6.73 | |||||
| Net Debt/EBITDA | 5.80 | 2.12 | 2.05 | 13.9 | 4.47 |
| balance sheet | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| balance sheet | ||||||||||||
| Cash & Cash Equivalents | CHF mil | 31.6 | 21.5 | 25.5 | 25.4 | 108 | ||||||
| Receivables | CHF mil | 73.8 | 80.5 | 72.5 | 71.4 | 84.0 | ||||||
| Unbilled Revenues | CHF mil | ... | ... | ... | ... | ... | ... | ... | ... | 4.72 | ||
| Inventories | CHF mil | 34.4 | 36.1 | 34.8 | 48.3 | 59.3 | ||||||
| Other ST Assets | CHF mil | 9.90 | 7.09 | 9.49 | 14.6 | 17.5 | ||||||
| Current Assets | CHF mil | 150 | 145 | 142 | 160 | 273 | ||||||
| Property, Plant & Equipment | CHF mil | 19.1 | 23.6 | 26.2 | 26.2 | 29.7 | ||||||
| LT Investments & Receivables | CHF mil | 0.833 | 0.834 | 0.697 | 1.83 | 0.981 | ||||||
| Intangible Assets | CHF mil | 50.4 | 50.3 | 53.7 | 63.1 | 148 | ||||||
| Goodwill | CHF mil | 11.2 | 11.0 | 10.5 | 10.4 | 83.1 | ||||||
| Non-Current Assets | CHF mil | 75.5 | 83.0 | 91.1 | 102 | 188 | ||||||
| Total Assets | CHF mil | 225 | 228 | 233 | 262 | 462 | ||||||
| Trade Payables | CHF mil | 62.6 | 63.3 | 72.2 | 70.7 | 75.3 | ||||||
| Short-Term Debt | CHF mil | 0.500 | 0.500 | 0.500 | 50.0 | 10.4 | ||||||
| Other ST Liabilities | CHF mil | 6.00 | 4.21 | 3.06 | 3.75 | 13.0 | ||||||
| Current Liabilities | CHF mil | 86.8 | 84.1 | 88.7 | 138 | 119 | ||||||
| Long-Term Debt | CHF mil | 58.1 | 57.8 | 57.4 | 5.00 | 2.85 | ||||||
| Other LT Liabilities | CHF mil | 6.78 | 8.93 | 14.6 | 14.5 | 45.6 | ||||||
| Non-Current Liabilities | CHF mil | 64.9 | 66.7 | 72.0 | 19.5 | 48.5 | ||||||
| Liabilities | CHF mil | 152 | 151 | 161 | 158 | 168 | ||||||
| Preferred Equity and Hybrid Capital | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||
| Share Capital | CHF mil | 18.7 | 18.7 | 18.7 | 24.9 | 35.8 | ||||||
| Treasury Stock | CHF mil | 1.34 | 1.31 | 1.03 | 0.903 | 1.22 | ||||||
| Equity Before Minority Interest | CHF mil | 73.4 | 77.4 | 72.8 | 104 | 294 | ||||||
| Minority Interest | CHF mil | 0 | 0 | 0 | 0 | 0.219 | ||||||
| Equity | CHF mil | 73.4 | 77.4 | 72.8 | 104 | 294 | ||||||
| growth rates | ||||||||||||
| Total Asset Growth | % | ... | -15.3 | 1.33 | 2.33 | 12.0 | 76.6 | |||||
| Shareholders' Equity Growth | % | ... | -14.9 | 5.41 | -5.91 | 42.6 | 183 | |||||
| Net Debt Growth | % | ... | 17.0 | 36.0 | -11.9 | -8.72 | -420 | |||||
| Total Debt Growth | % | ... | -25.2 | -0.595 | -0.601 | -5.09 | -75.9 | |||||
| ratios | ||||||||||||
| Total Debt | CHF mil | 58.6 | 58.3 | 57.9 | 55.0 | 13.2 | ||||||
| Net Debt | CHF mil | 27.0 | 36.8 | 32.4 | 29.6 | -94.7 | ||||||
| Working Capital | CHF mil | 45.6 | 53.2 | 35.1 | 48.9 | 68.0 | ||||||
| Capital Employed | CHF mil | 121 | 136 | 126 | 151 | 256 | ||||||
| Net Debt/Equity | % | 36.9 | 47.5 | 44.5 | 28.5 | -32.2 | ||||||
| Current Ratio | 1.72 | 1.73 | 1.60 | 1.16 | 2.30 | |||||||
| Quick Ratio | 1.21 | 1.21 | 1.11 | 0.700 | 1.61 |
| cash flow | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| cash flow | ||||||||||||
| Net Profit | CHF mil | -15.5 | 7.15 | 3.45 | -12.8 | -36.2 | ||||||
| Depreciation | CHF mil | 2.86 | 2.25 | 2.33 | 3.25 | 3.85 | ||||||
| Non-Cash Items | CHF mil | -1.04 | -4.12 | 0.631 | 4.67 | 2.62 | ||||||
| Change in Working Capital | CHF mil | 2.58 | -4.97 | 7.43 | -14.9 | -5.73 | ||||||
| Total Cash From Operations | CHF mil | 2.00 | 7.20 | 18.9 | -13.8 | -22.2 | ||||||
| Capital Expenditures | CHF mil | -10.5 | -15.8 | -15.2 | -19.9 | -21.6 | ||||||
| Net Change in LT Investment | CHF mil | 0.470 | 0.005 | -0.272 | -1.28 | -0.121 | ||||||
| Net Cash From Acquisitions | CHF mil | -1.03 | -0.165 | -0.904 | -2.15 | -40.9 | ||||||
| Other Investing Activities | CHF mil | 0 | 0 | 0 | 0.261 | 0.432 | ||||||
| Total Cash From Investing | CHF mil | -11.1 | -16.0 | -16.4 | -23.1 | -62.2 | ||||||
| Dividends Paid | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||
| Issuance Of Shares | CHF mil | 4.33 | -0.555 | 0.034 | 42.5 | 222 | ||||||
| Issuance Of Debt | CHF mil | -17.7 | -0.500 | 4.39 | -3.87 | -56.1 | ||||||
| Other Financing Activities | CHF mil | -1.51 | 0 | -1.92 | -1.64 | 0 | ||||||
| Total Cash From Financing | CHF mil | -14.9 | -1.06 | 2.50 | 37.0 | 166 | ||||||
| Effect of FX Rates | CHF mil | 0.331 | -0.223 | -0.999 | 0.037 | 1.07 | ||||||
| Net Change In Cash | CHF mil | -23.7 | -10.1 | 3.97 | 0.136 | 82.5 | ||||||
| ratios | ||||||||||||
| Days Sales Outstanding | days | 29.6 | 32.1 | 31.7 | 29.6 | 31.2 | ||||||
| Cash Earnings | CHF mil | -12.6 | 9.40 | 5.78 | -9.52 | -32.4 | ||||||
| Free Cash Flow | CHF mil | -9.09 | -8.79 | 2.47 | -36.9 | -84.4 | ||||||
| Capital Expenditures (As % of Sales) | % | 1.16 | 1.73 | 1.82 | 2.27 | 2.20 |
| other ratios | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Employees | 736 | 702 | 716 | 752 | 1,106 | |||||||
| Cost Per Employee | USD per month | 7,389 | 7,294 | 6,299 | 6,634 | 5,923 | ||||||
| Cost Per Employee (Local Currency) | CHF per month | 6,848 | 6,866 | 6,255 | 6,667 | 5,903 | ||||||
| Operating Cost (As % of Sales) | % | 102 | 99.7 | 99.7 | 101 | 105 | ||||||
| Research & Development (As % of Sales) | % | 0 | 0 | 0 | 0 | 0 | ||||||
| Staff Cost (As % of Sales) | % | 6.64 | 6.32 | 6.44 | 6.84 | 7.97 | ||||||
| Effective Tax Rate | % | -8.31 | -58.3 | 14.8 | -0.417 | 0.660 | ||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 11.6 | 11.3 | 12.5 | 13.4 | ||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Customers | mil | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| valuation | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Market Capitalisation | USD mil | 90.2 | 77.1 | 72.3 | 320 | 832 | ||||||
| Enterprise Value (EV) | USD mil | 116 | 113 | 104 | 349 | 735 | ||||||
| Number Of Shares | mil | 3.07 | 3.21 | 3.21 | 3.55 | 5.22 | ||||||
| Share Price | CHF | 25.0 | 23.9 | 22.5 | 75.7 | 131 | ||||||
| EV/EBITDA | 23.2 | 6.12 | 6.54 | 165 | -34.6 | |||||||
| Price/Earnings (P/E) | -4.96 | 10.7 | 21.0 | -21.0 | -18.9 | |||||||
| Price/Cash Earnings (P/CE) | -6.09 | 8.17 | 12.5 | -28.2 | -21.1 | |||||||
| P/FCF | -8.44 | -8.74 | 29.2 | -7.27 | -8.09 | |||||||
| Price/Book Value (P/BV) | 1.05 | 0.993 | 0.992 | 2.59 | 2.32 | |||||||
| Dividend Yield | % | 0 | 0 | 0 | 0 | 0 | ||||||
| Free Cash Flow Yield | % | -10.9 | -12.1 | 3.44 | -11.5 | -10.2 | ||||||
| Earnings Per Share (EPS) | CHF | -5.04 | 2.23 | 1.07 | -3.60 | -6.94 | ||||||
| Cash Earnings Per Share | CHF | -4.10 | 2.93 | 1.80 | -2.68 | -6.21 | ||||||
| Free Cash Flow Per Share | CHF | -2.96 | -2.74 | 0.770 | -10.4 | -16.2 | ||||||
| Book Value Per Share | CHF | 23.9 | 24.1 | 22.7 | 29.3 | 56.4 | ||||||
| Dividend Per Share | CHF | 0 | 0 | 0 | 0 | 0 | ||||||
| EV/Sales | 0.119 | 0.116 | 0.124 | 0.398 | 0.745 | |||||||
| EV/EBIT | -9.59 | 12.9 | 12.2 | -49.4 | -19.1 | |||||||
| EV/Free Cash Flow | -11.9 | -12.1 | 41.8 | -9.49 | -8.67 | |||||||
| EV/Capital Employed | 0.989 | 0.852 | 0.843 | 2.36 | 2.79 | |||||||
| Earnings Per Share Growth | % | ... | -348 | -144 | -52.0 | -436 | 92.8 | |||||
| Cash Earnings Per Share Growth | % | ... | -240 | -171 | -38.5 | -249 | 131 | |||||
| Book Value Per Share Growth | % | ... | -16.3 | 0.691 | -5.77 | 29.0 | 92.6 | |||||
| Market Value per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Sales per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| EBITDA per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Net Profit per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| clients & arpu | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Customers | mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Basket Size (USD) | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Order Frequency | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||
| Repeat Order Rate | % | ... | ... | ... | ... | ... | ... | ... | 84.0 | 87.0 | ||
| Site Visits | mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Marketing Expenses | CHF mil | ... | ... | ... | ... | ... | ... | ... | 22.2 | 33.7 | ||
| Marketing Expenses (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | 2.53 | 3.43 |
Get all company financials in excel:
By Helgi Analytics - August 2, 2020
Zur Rose made a net profit of CHF -52.4 mil with revenues of CHF 1,356 mil in 2019, down by 34.4% and up by 12.3%, respectively, compared to the previous year. This translates into a net margin of -3.86%. Historically, between 2009 - 2019, the fi...
By Helgi Analytics - August 2, 2020
Zur Rose employed 1,710 employees in 2019, up 30.1% compared to the previous year. Historically, between 2009 and 2019, the firm's workforce hit a high of 1,710 employees in 2019 and a low of 321 employees in 2010. Average personnel cost stood at USD...
By Helgi Analytics - August 2, 2020
Zur Rose stock traded at CHF 107 per share at the end 2019 translating into a market capitalization of USD 961 mil. Since the end of 2014, stock has appreciated by 348% representing an annual average growth of 35.0%. In absolute terms, the value of the ...
By Helgi Analytics - August 2, 2020
Zur Rose's net debt stood at CHF 233 mil and accounted for 57.4% of equity at the end of 2019. The ratio is up 76.0 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 57.4% in 2019 and a low of -32...
By Helgi Analytics - August 2, 2020
Zur Rose invested a total of CHF 41.5 mil in 2019, up 31.8% compared to the previous year. Historically, between 2009 - 2019, the company's investments stood at a high of CHF 41.5 mil in 2019 and a low of CHF 1.73 mil in 2009. As a pe...
By Helgi Analytics - August 2, 2020
Zur Rose made a net profit of CHF -52.4 mil with revenues of CHF 1,356 mil in 2019, down by 34.4% and up by 12.3%, respectively, compared to the previous year. This translates into a net margin of -3.86%. Historically, between 2009 and 2019, the fir...
By Helgi Analytics - August 2, 2020
Zur Rose stock traded at CHF 107 per share at the end 2019 implying a market capitalization of USD 961 mil. Since the end of 2014, stock has appreciated by 348% implying an annual average growth of 35.0% In absolute terms, the value of the company rose ...
By Helgi Analytics - August 2, 2020
Zur Rose stock traded at CHF 107 per share at the end 2019 translating into a market capitalization of USD 961 mil. Since the end of 2014, the stock has appreciated by 348% representing an annual average growth of 35.0%. At the end of 2019, the firm trad...
By Helgi Analytics - August 2, 2020
Zur Rose made a net profit of CHF -52.4 mil in 2019, down 34.4% compared to the previous year. Historically, between 2009 and 2019, the company's net profit reached a high of CHF 40.6 mil in 2009 and a low of CHF -52.4 mil in 2019. The result implies a re...
The Swiss Zur Rose Group is Europe’s largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland. The Company also operates the leading marketplace in southern Europe for consumer health, beauty and personal care products commonly sold in pharmacies. The company is internationally present with strong brands, including Germany’s best-known pharmacy brand DocMorris. Zur Rose employs more than 1,800 people at sites in Switzerland, Germany, the Netherlands, Spain and France. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Zur Rose has been growing its sales by 8.16% a year on average in the last 5 years. EBITDA has fallen by 180% during that time to total of CHF -13.8 mil in 2019, or -1.02% of sales. That’s compared to -0.440% average margin seen in last five years.
The company netted CHF -52.4 mil in 2019 implying ROE of -12.3% and ROCE of -9.90%. Again, the average figures were -10.2% and -9.28%, respectively when looking at the previous 5 years.
Zur Rose’s net debt amounted to CHF 233 mil at the end of 2019, or 57.4% of equity. When compared to EBITDA, net debt was -16.8x, down when compared to average of 1.91x seen in the last 5 years.
Zur Rose stock traded at CHF 107 per share at the end of 2019 resulting in a market capitalization of USD 961 mil. Over the previous five years, stock price grew by 348% or 35.0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of -84.8x and price to earnings (PE) of -17.7x as of 2019.
Helgi Analytics 
